Profile | GDS4284 / 1569637_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 39.2188 | 21 |
GSM687648 | Patient 402 control | 40.492 | 21 |
GSM687653 | Patient 403 control | 45.6435 | 22 |
GSM687658 | Patient 404 control | 11.0407 | 6 |
GSM687663 | Patient 411 control | 133.836 | 39 |
GSM687668 | Patient 422 control | 24.9098 | 15 |
GSM687673 | Patient 424 control | 6.6678 | 2 |
GSM687678 | Patient 425 control | 90.2401 | 31 |
GSM687683 | Patient 427 control | 71.4865 | 27 |
GSM687688 | Patient 428 control | 77.064 | 30 |
GSM687695 | Patient 441 control | 97.1947 | 25 |
GSM687699 | Patient 443 control | 104.542 | 31 |
GSM687704 | Patient 444 control | 39.0875 | 20 |
GSM687707 | Patient 448 control | 84.122 | 27 |
GSM687712 | Patient 449 control | 71.9425 | 28 |
GSM687719 | Patient 450 control | 57.2876 | 22 |
GSM687724 | Patient 451 control | 72.8182 | 26 |
GSM687728 | Patient 452 control | 90.952 | 30 |
GSM687646 | Patient 401 treated 24h | 136.943 | 41 |
GSM687649 | Patient 402 treated 24h | 62.0284 | 28 |
GSM687665 | Patient 411 treated 24h | 90.0207 | 30 |
GSM687651 | Patient 402 treated 4 weeks | 82.558 | 30 |
GSM687667 | Patient 411 treated 4 weeks | 162.379 | 44 |
GSM687670 | Patient 422 treated 24h | 76.4829 | 28 |
GSM687671 | Patient 422 treated 4 weeks | 4.28073 | 1 |
GSM687654 | Patient 403 treated 24h | 10.2363 | 6 |
GSM687675 | Patient 424 treated 24h | 59.3944 | 24 |
GSM687685 | Patient 427 treated 24h | 71.7965 | 28 |
GSM687656 | Patient 403 treated 4 weeks | 57.21 | 27 |
GSM687677 | Patient 424 treated 4 weeks | 46.9134 | 22 |
GSM687687 | Patient 427 treated 4 weeks | 120.366 | 40 |
GSM687692 | Patient 428 treated 4h | 111.921 | 36 |
GSM687716 | Patient 449 treated 4h | 105.278 | 36 |
GSM687722 | Patient 450 treated 4h | 19.9237 | 9 |
GSM687680 | Patient 425 treated 24h | 98.0785 | 34 |
GSM687690 | Patient 428 treated 24h | 104.178 | 36 |
GSM687700 | Patient 443 treated 24h | 141.146 | 33 |
GSM687705 | Patient 444 treated 24h | 95.9124 | 35 |
GSM687714 | Patient 449 treated 24h | 63.2341 | 28 |
GSM687721 | Patient 450 treated 24h | 65.6658 | 24 |
GSM687682 | Patient 425 treated 4 weeks | 64.3105 | 27 |
GSM687694 | Patient 428 treated 4 weeks | 75.8506 | 31 |
GSM687702 | Patient 443 treated 4 weeks | 142.691 | 39 |
GSM687718 | Patient 449 treated 4 weeks | 44.666 | 21 |
GSM687723 | Patient 450 treated 4 weeks | 113.919 | 35 |
GSM687661 | Patient 404 treated 4h | 57.0746 | 24 |
GSM687710 | Patient 448 treated 4h | 108.788 | 36 |
GSM687726 | Patient 451 treated 4h | 51.211 | 22 |
GSM687730 | Patient 452 treated 4h | 486.787 | 55 |
GSM687660 | Patient 404 treated 24h | 58.762 | 21 |
GSM687697 | Patient 441 treated 24h | 70.1496 | 23 |
GSM687709 | Patient 448 treated 24h | 60.2614 | 24 |
GSM687725 | Patient 451 treated 24h | 137.866 | 36 |
GSM687729 | Patient 452 treated 24h | 91.594 | 26 |
GSM687727 | Patient 451 treated 4 weeks | 108.477 | 32 |
GSM687731 | Patient 452 treated 4 weeks | 118.084 | 35 |